4//SEC Filing
Smith W Bradford 4
Accession 0000899243-22-008064
CIK 0001661998other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:06 PM ET
Size
7.9 KB
Accession
0000899243-22-008064
Insider Transaction Report
Form 4
Smith W Bradford
CFO, Treasurer & Secretary
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-02-24+126,000→ 126,000 totalExercise: $2.71Exp: 2032-02-24→ Common Stock (126,000 underlying) - Award
Restricted Stock Units
2022-02-24+21,000→ 21,000 total→ Common Stock (21,000 underlying)
Footnotes (3)
- [F1]The option vests in 48 substantially equal monthly installments on the first day of each calendar month following January 1, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001317678
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:06 PM ET
- Size
- 7.9 KB